Pamela Stephenson - 27 Sep 2021 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 Sep 2021
Net transactions value
-$14,456
Form type
4
Filing time
28 Sep 2021, 16:32:33 UTC
Previous filing
05 Aug 2021
Next filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $14,456 -451 -1.7% $32.05 26,063 27 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 11,188 shares of common stock and 14,875 restricted stock units.